MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

MYOMO, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$1.25+0.05 (+4.17%)

Close on Oct 19, 2026

Market cap: $53.37M
P/E (TTM): –
Dividend yield: –

Dividends

Myomo has not reported a dividend

No dividend per share appears in Myomo's annual filings since fiscal 2015.

Where these numbers come from

Parsed from the XBRL in Myomo's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Mar 13, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MYO.

Revenue growth6.1% · median 9.3%

Gross margin68.4% · median 57.9%

Operating margin-27.1% · median 7.5%

Net margin-33.5% · median -39.4%

Company	Revenue	Growth
SMTI	$109.81M	+13.0%
APT	$61.91M	+5.7%
MYO	$43.26M	+6.1%
UTMD	$36.11M	–
LFWD	$21.82M	-10.7%
LGMK	$12.54M	+20.6%

Company

Next earnings (est.): Nov 9, 2026, after close
Exchange: NYSE
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends: December 31
Employees: 184
Held by institutions: 30.8%
Auditor: Marcum LLP
SEC CIK: 1369290

Advertisement
300 × 250